Loading…
Reported covered position: Senior Advisor/Chief of Staff, Center for Medicare and Medicaid Services; Senior Policy Advisor, Office of White House Policy, Domestic Policy Council; Legislative Assistant, Sen. Mark Warner.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SPRINGER NATURE AMERICA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
Source: Senate LDA
| TeleTracking Technologies, Inc. |
| 7 |
| 2021–2023 |
| COLOR HEALTH (FKA COLOR GENOMICS) | 6 | 2018–2019 |
| DELTA DENTAL PLANS ASSOCIATION | 6 | 2023–2024 |
| SCIPHER MEDICINE CORPORATION | 6 | 2023–2024 |
| CRISIS TEXT LINE, INC. | 3 | 2019 |
| PHARMATROPHIX, INC. | 3 | 2026 |
| SPRINGER NATURE AMERICA, INC. | 2 | 2026 |
Lobbying related to scientific publishing and research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATROPHIX, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to clinical trial funding.
Lobbying related to clinical trial funding.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to higher education and health research.
Lobbying related to health research.
Lobbying related to higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPRINGER NATURE AMERICA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · RR
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
PHARMATROPHIX, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to clinical trial funding.
Lobbying related to clinical trial funding.
Filing targets: Executive Office of the President (EOP), SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to higher education.
Lobbying related to higher education and health research.
Lobbying related to health research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMATROPHIX, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · RR
Lobbying related to clinical trial funding.
Lobbying related to clinical trial funding.
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Lobbying related to health care issues.
Lobbying related to health care issues.
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Lobbying on higher education.
Lobbying on health care.
Lobbying related to higher education, health care, and research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Lobbying related to higher education, health care, and research funding.
Lobbying on health care.
Lobbying on higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Lobbying related to health care issues.
Lobbying related to health care issues.
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to higher education, health care, and research funding.
Lobbying on health care.
Lobbying on higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to higher education, health care, and research funding.
Lobbying on health care.
Lobbying on higher education.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · RA
Higher education, health research
Higher education, health research
Higher education, health research
JOHNS HOPKINS UNIVERSITY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · RA
Higher education, health research
Higher education, health research
Higher education, health research
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · 1T
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · 1T
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · 1T
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: Health & Human Services, Dept of (HHS)
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · RR
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · 1T
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · RR
Lobbying related to CMS coverage determination
Lobbying related to CMS coverage determination
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: Health & Human Services, Dept of (HHS)
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · RR
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · RR
Lobbying on diabetes reversal, telehealth and related metabolic disease issues.
Lobbying on diabetes reversal, telehealth and related metabolic disease issues.
Lobbying on diabetes reversal, telehealth and related metabolic disease issues.
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · second_quarter · Q2
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTUITIVE SURGICAL, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · second_quarter · Q2
Lobbying related to health care issues.
Lobbying related to health care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · first_quarter · Q1
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE